AI Development

Reid Hoffman exits Microsoft board to focus on AI drug discovery startup

June 6, 2026 · High importance · strategy
Editorial Analysis

LinkedIn co-founder Reid Hoffman announced his departure from Microsoft's board after seven years to dedicate more time to Manas, his AI-focused drug discovery startup. This reflects the growing intersection of AI and biotechnology.

At a Glance
Date
June 6, 2026
Importance
High 4/5
Category
strategy
Axis of Change
Strategic Realignment
Organizations
Microsoft
Models Affected
No specific model identified
Sources
  1. 01 livemint.com
Related Developments
Sep 18, 2026 · strategy

Anthropic considers new model release ahead of expected IPO
Sep 15, 2026 · strategy

Meta CEO Mark Zuckerberg rejects coordinated AI slowdown calls
Sep 12, 2026 · strategy

Sam Altman signals possible safety coordination among frontier labs